Cargando…
CRISPR-cas13 enzymology rapidly detects SARS-CoV-2 fragments in a clinical setting
BACKGROUND: The well-recognized genome editing ability of the CRISPR-Cas system has triggered significant advances in CRISPR diagnostics. This has prompted an interest in developing new biosensing applications for nucleic acid detection. Recently, such applications have been engineered for detection...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553369/ https://www.ncbi.nlm.nih.gov/pubmed/34753073 http://dx.doi.org/10.1016/j.jcv.2021.105019 |